Patent ID: 6190693
Filing Date: 2001-02-20
Classification: A61K,A61P

Abstract:
A method of administering folic acid to a subject for whom a hormonal replacement composition is indicated for treating or preventing a menopausal condition, which comprises administering to the subject a pharmaceutical composition, wherein(a) the pharmaceutical composition comprises a hormonal replacement composition for treating or preventing a menopausal condition in a subject, and folic acid in an amount sufficient to treat or prevent a disorder which (i) afflicts subjects for whom the hormonal replacement composition is indicated at a higher-than-normal incidence, and (ii) is treatable or preventable by folic acid administration, and(b) the subject is from a population whose members are afflicted with, or predisposed to become afflicted with, a disorder at a higher-than-normal incidence, the disorder being treatable or preventable by folic acid administration.